PEOPLE - PowderJect Pharmaceuticals makes appointment:
This article was originally published in Clinica
PowderJect Pharmaceuticals, a UK developer of powder injection systems, has appointed Dr Steven Prestrelski to the new post of vice-president of biopharmaceuticals. Dr Prestrelski, who joins from Alza, a US drug delivery company, will oversee PowderJect's efforts in formulating biomolecules for delivery by the PowderJect device.
You may also be interested in...
Johnson & Johnson believes personalization via digital holds the key to smoking cessation success as it launches in the UK its app-supported Nicorette QuickMist SmartTrack product.
China’s Bio-Thera Solutions has ventured outside of its domestic market for the first time by filing an application for a biosimilar version of Avastin with the European Medicines Agency. The company has also revealed its timeline for a submission to the FDA.
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.